Karen Murray, MD
Primary Location
Cleveland Clinic Main Campus
- Appointment:
- 216.444.5437
- Desk:
- 216.445.9380
- Fax:
- 216.444.2974
Additional Locations
Pediatric Institute
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, OH 44195
Directions
- Desk:
- 216.445.9380
Pediatric Gastroenterology, Hepatology, and Nutrition
Medina Medical Office Building
970 E Washington St
Medina, OH 44256-3332
Directions
- Appointment:
- 216.444.5437
- Desk:
- 216.445.9380
- Fax:
- 216.444.2974
Treatment & Services
- Care of Liver Related Metabolic Problems
- Care of Liver Transplant Patients
- Center for Pediatric Gastroenterology
- Liver Biopsy
- Liver Transplant
- Outpatient Care
- Pediatric Gastroenterology
- Pediatric Liver Transplant
Specialty in Diseases & Conditions
- Alpha-1 Antitrypsin Deficiency
- Biliary Atresia
- Cirrhosis
- Diseases of the Liver, Biliary Tract and Pancreas
- Gallbladder Disease
- Hepatitis B
- Hepatitis C
- Liver Disease
- Non-Alcoholic Fatty Liver Disease
- Primary Sclerosing Cholangitis
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Karen Murray, MD
Karen F. Murray, MD, is the Chair, Pediatric Institute, Physician-in-Chief of Cleveland Clinic Children’s, and President, Cleveland Clinic Children’s Hospital for Rehabilitation, at Cleveland Clinic Children’s. Formerly, she was Professor and Division Chief of Pediatric Gastroenterology and Hepatology, Vice Chair of Clinical Affairs, Department of Pediatrics, University of Washington School of Medicine and Seattle Children’s Hospital.
She received her MD from Johns Hopkins School of Medicine and did a pediatrics residency and a chief resident year at Seattle Children's. She completed a clinical and research fellowship in gastroenterology in the combined program at Children's Hospital Boston and Massachusetts General Hospital, Harvard Medical School. Murray is certified in gastroenterology and transplant hepatology, and chaired the Gastroenterology Sub-board of the American Board of Pediatrics (ABP) and served on the New Subspecialties Committee of the ABP from 2012-2018. In addition to clinical care in gastroenterology and transplantation, she has an active clinical research program in hepatology. Her main focus is in the treatment and pathophysiology of childhood liver disease, with focus on the treatment of hepatitis B and C viral infections, non-alcoholic fatty liver disease, and cholestatic liver diseases in childhood. Murray is past-president of Seattle Children’s medical staff. She is on the steering committees of three National Institute of Diabetes and Digestive and Kidney Diseases clinical research networks related to her research, and is currently serving as President of the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition.
Education & Professional Highlights
Appointed
2019
Education & Fellowships
Fellowship - Boston Children's Hospital
Pediatric Gastroenterology
Boston,,
MA
1997
Residency - Children's Hospital & Regional Medical Center
Pediatrics
Seattle,
WA
1994
Medical Education - Johns Hopkins School of Medicine
Medicine
Baltimore,
MD
1990
Undergraduate - Cornell University
Nutritional Biochemistry
Ithaca,
NY United States
1986
Certifications
- Pediatrics
- Pediatrics - Pediatric Gastroenterology
- Pediatrics - Pediatric Transplant Hepatology
Research & Publications
See publications for Karen Murray, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/21/2025, Dr. Murray has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Murray receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Albireo Pharma, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
